{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:01:07Z","timestamp":1790881267678,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2003,4,1]],"date-time":"2003-04-01T00:00:00Z","timestamp":1049155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2003,4,1]],"date-time":"2003-04-01T00:00:00Z","timestamp":1049155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2003,4,1]]},"DOI":"10.1038\/sj.bmt.1703917","type":"journal-article","created":{"date-parts":[[2003,4,11]],"date-time":"2003-04-11T16:31:03Z","timestamp":1050078663000},"page":"679-685","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":122,"title":["High-dose thiotepa, busulfan, cyclophosphamide and ASCT without whole-brain radiotherapy for poor prognosis primary CNS lymphoma"],"prefix":"10.1038","volume":"31","author":[{"given":"T","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Forsyth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Chaudhry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Gl\u00fcck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J A","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D A","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2003,4,11]]},"reference":[{"key":"BF1703917_CR1","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1002\/(SICI)1097-0142(19970615)79:12<2409::AID-CNCR17>3.0.CO;2-V","volume":"79","author":"WC Benjamin","year":"1997","unstructured":"Benjamin WC, Marcus SM, Topham A et al. Will primary central nervous system lymphoma be the most frequent brain tumor diagnosed in the year 2000? Cancer 1997; 79: 2409\u20132413.","journal-title":"Cancer"},{"key":"BF1703917_CR2","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1023\/A:1008376412784","volume":"11","author":"AJ Ferreri","year":"2000","unstructured":"Ferreri AJ, Reni M, Villa E . Therapeutic management of primary central nervous system lymphoma: lessons from prospective trials. Ann Oncol 2000; 11: 927\u2013937.","journal-title":"Ann Oncol"},{"key":"BF1703917_CR3","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1212\/WNL.46.6.1757","volume":"46","author":"L Cher","year":"1996","unstructured":"Cher L, Glass J, Harsh GR et al. Therapy of primary CNS lymphoma with methotrexate-based chemotherapy and deferred radiotherapy: preliminary results. Neurology 1996; 46: 1757\u20131759.","journal-title":"Neurology"},{"key":"BF1703917_CR4","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1002\/1097-0142(20000915)89:6<1359::AID-CNCR21>3.0.CO;2-9","volume":"89","author":"GM Mead","year":"2000","unstructured":"Mead GM, Bleehen NM, Gregor A et al. A medical research council randomized trial in patients with primary cerebral non-Hodgkin lymphoma. Cancer 2000; 89: 1359\u20131369.","journal-title":"Cancer"},{"key":"BF1703917_CR5","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1200\/JCO.1998.16.3.859","volume":"16","author":"LE Abrey","year":"1998","unstructured":"Abrey LE, DeAngelis LM, Yahalom J . Long-term survival in primary CNS lymphoma. J Clin Oncol 1998; 16: 859\u2013863.","journal-title":"J Clin Oncol"},{"key":"BF1703917_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0360-3016(92)90538-S","volume":"23","author":"DF Nelson","year":"1992","unstructured":"Nelson DF, Martz KL, Bonner H et al. Non-Hodgkin's lymphoma of the brain: can high-dose, large-volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315. Int J Radiat Oncol Biol Phys 1992; 23: 9\u201317.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BF1703917_CR7","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0167-8140(97)00074-1","volume":"43","author":"NJ Laperriere","year":"1997","unstructured":"Laperriere NJ, Crerzo L, Milosevic MF et al. Primary lymphoma of brain: results of magagement of a modern cohort with radiation therapy. Radiother Oncol 1997; 43: 247\u2013252.","journal-title":"Radiother Oncol"},{"key":"BF1703917_CR8","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1200\/JCO.1992.10.4.635","volume":"10","author":"LM DeAngelis","year":"1992","unstructured":"DeAngelis LM, Yahalom J, Thaler HT et al. Combined modality therapy for primary CNS lymphoma. J Clin Oncol 1992; 10: 635\u2013643.","journal-title":"J Clin Oncol"},{"key":"BF1703917_CR9","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1200\/JCO.1996.14.2.556","volume":"14","author":"C Schultz","year":"1996","unstructured":"Schultz C, Scott C, Sherman W et al. Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas: initial report of Radiation Therapy Oncology Group protocol 88-06. J Clin Oncol 1996; 14: 556\u2013564.","journal-title":"J Clin Oncol"},{"key":"BF1703917_CR10","doi-asserted-by":"publisher","first-page":"3144","DOI":"10.1200\/JCO.2000.18.17.3144","volume":"17","author":"LE Abrey","year":"2000","unstructured":"Abrey LE, Yahalom J, DeAngelis LM . Treatment for primary CNS lymphoma: the next step. J Clin Oncol 2000; 17: 3144\u20133150.","journal-title":"J Clin Oncol"},{"key":"BF1703917_CR11","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1023\/A:1006210703827","volume":"43","author":"N Guha-Thakurta","year":"1999","unstructured":"Guha-Thakurta N, Damek D, Pollack C et al. Intravenous methotrexate as initial treatment for primary central nervous system lymphoma: response to therapy and quality of life of patients. J Neurooncol 1999; 43: 259\u2013268.","journal-title":"J Neurooncol"},{"key":"BF1703917_CR12","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1200\/JCO.2002.20.1.231","volume":"20","author":"EM Bessell","year":"2002","unstructured":"Bessell EM, Lopez-Guillermo A, Villa S et al. Importance of radiotherapy in the outcome of patients with primary CNS lymphoma: an analysis of the CHOD\/BVAM regimen followed by tow different radiotherapy treatments. J Clin Oncol 2002; 20: 231\u2013236.","journal-title":"J Clin Oncol"},{"key":"BF1703917_CR13","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3109\/10428199609054837","volume":"23","author":"C Soussain","year":"1996","unstructured":"Soussain C, Merle-Beral H, Reux I et al. A single-center study of 11 patients with intraocular lymphoma treated with conventional chemotherapy followed by high-dose chemotherapy and autologous bone marrow transplantation in 5 cases. Leuk Lymphoma 1996; 23: 339\u2013345.","journal-title":"Leuk Lymphoma"},{"key":"BF1703917_CR14","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1200\/JCO.2001.19.3.742","volume":"19","author":"C Soussain","year":"2001","unstructured":"Soussain C, Suzan F, Hoang-Xuan K et al. Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma. J Clin Oncol 2001; 19: 742\u2013749.","journal-title":"J Clin Oncol"},{"key":"BF1703917_CR15","doi-asserted-by":"publisher","first-page":"3036","DOI":"10.1200\/JCO.1996.14.11.3036","volume":"14","author":"K van Besien","year":"1996","unstructured":"van Besien K, Przepiorka D, Mehra R et al. Impact of preexisting CNS involvement on the outcome of bone marrow transplantation in adult hematologic malignancies. J Clin Oncol 1996; 14: 3036\u20133042.","journal-title":"J Clin Oncol"},{"key":"BF1703917_CR16","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/sj.bmt.1702833","volume":"27","author":"AK Gopal","year":"2001","unstructured":"Gopal AK, Gooley TA, Golden JB et al. Efficacy of high-dose therapy and autologous hematopoietic stem cell transplantation for non-Hodgkin's lymphoma in adults 60 years of age and older. Bone Marrow Transplant 2001; 27: 593\u2013599.","journal-title":"Bone Marrow Transplant"},{"key":"BF1703917_CR17","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3171\/jns.1994.81.2.0188","volume":"81","author":"J Glass","year":"1994","unstructured":"Glass J, Gruber ML, Cher L et al. Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma: long-term outcome. J Neurosurg 1994; 81: 188\u2013195.","journal-title":"J Neurosurg"},{"key":"BF1703917_CR18","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1200\/JCO.1998.16.3.864","volume":"16","author":"J Blay","year":"1998","unstructured":"Blay J, Conroy T, Chevreau C et al. High-dose methotrexate for the treatment of primary CNS lymphoma: analysis of survival and late neurologic toxicity in a retrospective series. J Clin Oncol 1998; 16: 864\u2013871.","journal-title":"J Clin Oncol"},{"key":"BF1703917_CR19","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1002\/1097-0142(19800401)45:7<1556::AID-CNCR2820450707>3.0.CO;2-B","volume":"45","author":"T Ervin","year":"1980","unstructured":"Ervin T, Canellos GP . Successful treatment of recurrent primary central nervous system lymphoma with high-dose methotrexate. Cancer 1980; 45: 1556\u20131557.","journal-title":"Cancer"},{"key":"BF1703917_CR20","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1001\/archinte.1986.00360160243032","volume":"146","author":"JC Frick","year":"1986","unstructured":"Frick JC, Hansen RM, Anderson T, Ritch PS . Successful high-dose intravenous cytarabine treatment of parenchymal involvement from malignant lymphoma. Arch Intern Med 1986; 146: 791\u2013792.","journal-title":"Arch Intern Med"},{"key":"BF1703917_CR21","first-page":"113","volume":"4","author":"M Hassan","year":"1989","unstructured":"Hassan M, Ehrsson H, Smedmyr B et al. Cerebrospinal fluid and plasma concentrations of busulfan during high-dose therapy. Bone Marrow Transplant 1989; 4: 113\u2013114.","journal-title":"Bone Marrow Transplant"},{"key":"BF1703917_CR22","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/1040-8428(92)90092-5","volume":"13","author":"VJ Wiebe","year":"1992","unstructured":"Wiebe VJ, Smith BR, DeGregorio MW, et al: Pharmacology of agents used in bone marrow transplant conditioning regimens. Crit Rev Oncol\/Hematol 1992; 13: 241\u2013270.","journal-title":"Crit Rev Oncol\/Hematol"},{"key":"BF1703917_CR23","first-page":"736","volume":"49","author":"RL Heideman","year":"1989","unstructured":"Heideman RL, Cole DE, Balis F et al. Phase I and pharmacokinetic evaluation of thiotepa in the cerebrospinal fluid and plasma of pediatric patients: evidence for dose-dependent plasma clearance of thiotepa. Cancer Res 1989; 49: 736\u2013741.","journal-title":"Cancer Res"},{"key":"BF1703917_CR24","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1023\/A:1008248315859","volume":"8","author":"K van Besien","year":"1997","unstructured":"van Besien K, Forman A, Champlin R . Central nervous system relapse of lymphoid malignancies in adults: the role of high-dose chemotherapy. Ann Oncol 1997; 8: 515\u2013524.","journal-title":"Ann Oncol"},{"key":"BF1703917_CR25","first-page":"1021","volume":"18","author":"S Khalfallah","year":"1996","unstructured":"Khalfallah S, Stamatoullas A, Fruchart C et al. Durable remission of a relapsing primary central nervous system lymphoma after autologous bone marrow transplantation. Bone Marrow Transplant 1996; 18: 1021\u20131023.","journal-title":"Bone Marrow Transplant"},{"issue":"Suppl 3","key":"BF1703917_CR26","first-page":"15","volume":"10","author":"R Marks","year":"1999","unstructured":"Marks R, Warnke P, Guttenberger R et al. Primary CNS lymphoma (PCNSL): high-dose chemotherapy with autologous PBSCT and hyperfractionated radiotherapy within first-line treatment. Ann Oncol 1999; 10: (Suppl 3): 15 (Abstr. 42).","journal-title":"Ann Oncol"},{"key":"BF1703917_CR27","first-page":"53a","volume":"20","author":"LE Abrey","year":"2001","unstructured":"Abrey LE, Moskowitz CH, Mason WP et al. A phase II study of intensive methotrexate and cytarabine followed by high dose BEAM chemotherapy with autologous stem cell transplantation (ASCT) in patients with newly diagnosed primary central nervous system lymphoma (PCNSL). Proc ASCO 2001; 20: 53a (Abstr. 207).","journal-title":"Proc ASCO"},{"key":"BF1703917_CR28","first-page":"2330","volume-title":"Cancer: Principles & Practice of Oncology, 6th edn","author":"LM DeAngelis","year":"2001","unstructured":"DeAngelis LM, Yahalom J . Primary central nervous system lymphoma. In: DeVita VT (ed). Cancer: Principles & Practice of Oncology, 6th edn. Lippincott Williams & Wilkins: Philadelphia, 2001, pp 2330\u20132339."}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1703917","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1703917.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1703917.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T23:36:50Z","timestamp":1648078610000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1703917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,4,1]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2003,4,1]]}},"alternative-id":["BF1703917"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1703917","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,4,1]]},"assertion":[{"value":"24 April 2002","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2002","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2003","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}